Delivery Order HHSN271201700006I-75N95022F00002
Award Date 9/29/22
Potential Completion Date 6/30/27
Potential Value $616K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
Kansas City, MO 64110, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
2
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $92,605 firm fixed price delivery order to Mriglobal, doing business as Midwest Research Institute, an independent not-for-profit research organization. The order is part of the $100 million IDIQ contract vehicle from HHS ASPR to maintain nonclinical laboratory networks evaluating medical countermeasures. This delivery order is for ML-246 (METARRESTIN)...
- This task order was awarded by the National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to Mriglobal, doing business as Midwest Research Institute, a not-for-profit research organization. The task order, valued at $131,421.00, is for analytical method development and validation, characterization, and stability studies of the drug substance ML-246 under the parent contract "CRO Support for NCATS Drug Substance Development and Manufacture." The...
- This is a $4,415,116.56 cost-plus-fixed-fee contract awarded by the National Cancer Institute (NCI), part of the Department of Health and Human Services (HHS), to Mriglobal, doing business as Midwest Research Institute, to provide shelf life evaluation of investigational dosage forms. The contract does not have a small business set-aside designation. Mriglobal is an independent, not-for-profit research organization that conducts over $110 million in research annually for federal and commercial...
- The National Center for Advancing Translational Sciences (NCATS) awarded a $739,894 firm fixed-price purchase order to Mriglobal (doing business as Midwest Research Institute) on September 16, 2025, for the procurement of API and diluent. The contract, which carries no set-aside designation, is scheduled for completion by September 19, 2028, and will be performed in Potomac, Maryland. Mriglobal is a Kansas City-based 501(c)(3) not-for-profit research organization with over $110 million in annual...
- This is a cost-plus-fixed-fee delivery order contract awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Mriglobal, doing business as Midwest Research Institute, a non-profit research organization. The contract is valued at $949,295.00 and will run through January 31, 2026. The contract is for the evaluation of the shelf-life of samples of investigational clinical drug formulations, including parenteral, oral, and other dosage...
- Mriglobal, doing business as Midwest Research Institute, received a definitive cost-plus-fixed-fee contract valued at approximately $19.1 million from an unspecified federal agency for research and development activities. The contract was awarded on July 1, 2005, with an ultimate completion date of November 15, 2005, and is to be performed in Kansas City, Missouri. No small business set-aside designation was applied to this award, reflecting Mriglobal's status as an experienced prime...
- This is a $99,500.00 delivery order contract awarded to Mriglobal, also doing business as Midwest Research Institute, by the Department of Health and Human Services' National Institutes of Health National Institute on Aging. The contract is for drug toxicity testing services, with a period of performance through July 31, 2024. The contract is not set aside for any small business program. Mriglobal is a 501(c)(3) non-profit research organization that specializes in scientific research, testing,...
- This is a $26,932,208.00 cost-plus-fixed-fee delivery order contract awarded by the National Cancer Institute, a civilian agency, to Mriglobal, doing business as Midwest Research Institute, a 501(c)(3) not-for-profit research organization. The contract is for a Centralized Chemopreventive Agent Repository and Chemistry Support and has an ultimate completion date of June 30, 2028. Mriglobal is the prime contractor and there is no set-aside designation indicated. The contract appears to be part of...
- This is a $114,038 cost-plus-fixed-fee delivery order awarded to Mriglobal, a 501(c)(3) not-for-profit research organization, by the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services. The delivery order is for contract management support activities under the BIO-AMT-2301 Indefinite Delivery/Indefinite Quantity (IDIQ) contract. No set-aside was used for this award. Mriglobal, which does business as Midwest Research...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse awarded a $1,596,279.92 cost-plus-fixed-fee delivery order contract to Midwest Research Institute (doing business as Mriglobal), a not-for-profit research organization, under the Drug Manufacturing and Formulation Program (DMFP) indefinite delivery/indefinite quantity (IDIQ) contract. The contract does not have a set-aside designation. Key subcontractors include the University...
- HHSN271201700006IIndefinite Delivery Contract
- HHSN271201700006I-75N95022F00002Delivery Order
The National Institutes of Health National Center for Advancing Translational Sciences awarded a $594,882 delivery order contract to Midwest Research Institute, doing business as Mriglobal, for Analytical Method Development, Validation and Stability Study of ORC-13661. This delivery order was issued against the prime contractor's master indefinite-delivery indefinite-quantity contract for Contract Research Organization Support for Drug Substance Development and Manufacture. Performance will take place in Kansas City, Missouri over a five-year period ending in September 2027. The contract utilizes a cost plus fixed fee pricing structure.
Generated 11/28/23, 2:07 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Supplemental Agreement for work within scope | $20.6k | 1/9/24 | |
| P00001 | Exercise an Option | $288.6k | 4/24/23 | |
| Not listed | Not listed | $172.8k | 9/29/22 |